Respiro program enables independent drugstores to access business resources from A&D Pharma group and to remain independent from the group.
A&D Pharma group plans to integrate a total 800 pharmacies within Respiro program, by the end of 2017.
A&D Pharma group includes Mediplus, which was market leader in 2016, with a turnover of EUR888 million, pharmacy chain Sensiblu, the second largest player on the market, with a turnover of EUR371 million in 2016, pharmacy chain Punkt, the group’s low-cost pharmaceutical retail brand, and the Marketing&Sales division.